Sandoz – Recall of ranitidine
September 23, 2019 - The FDA announced a consumer-level recall of several lots of Sandoz’s ranitidine capsules because of confirmed contamination with N-Nitrosodimethylamine (NDMA) above levels established by the FDA in batches of Sandoz’s ranitidine capsules.
Download PDF
